检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.

Daniel Bradshaw,Iga Abramowicz,Stephen Bremner,Sumita Verma,Yvonne Gilleece, Sarah Kirk,Mark Nelson,Rosalie Housman,Helena Miras,Chloe Orkin, Ashini Fox,Michael Curnock,Louise Jennings,Mark Gompels,Emily Clarke,Rachel Robinson, Pauline Lambert,David Chadwick,Nicky Perry

PloS one（2023）

引用 0|浏览17
暂无评分
摘要
Clinical trial registry: ISCRTN, registration number 31461655.
更多
查看译文
关键词
maraviroc,hiv,liver,non-alcoholic
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要